Machine Learning Approaches for Optimizing Drug Combinations in Neurodegenerative Diseases: A Brief Review
Open Access
- 30 November 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (48) , 57950-57973
Abstract
As the global population ages, the prevalence of neurodegenerative diseases (NDDs)including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Multisystem Atrophy (multiple system atrophy), and amyotrophic lateral sclerosiscontinues to rise, largely driven by environmental, metabolic, and lifestyle risk factors. Advances in computational technologies, particularly machine learning (ML) and deep learning, are reshaping research in this field. This review summarizes the major features of these diseases and emphasizes the role of ML in drug discovery, virtual screening, drug repurposing, and drug combination optimization. Representative approaches include support vector machines for classification, convolutional neural networks|convolutional neural network for imaging analysis, recurrent neural networks for temporal biomedical data, and transformers for multimodal integration. These methods highlight the potential of computational strategies to improve therapeutic development. In addition, the review underscores the substantial incidence rates and socioeconomic burden of these conditions, which have made them focal points for algorithmic innovation. With research evolving rapidly, the development of AI-driven approaches is expected to enable more effective, targeted interventions and improve patient outcomes. This Perspective provides a concise overview of current progress and identifies promising future directions in the fight against NDDs.Keywords
Funding Information
- Natural Science Foundation of Guangxi Zhuang Autonomous Region (2025GXNSFAA069529, 2025GXNSFAA069829)
- National Natural Science Foundation of China (22078073)
This publication has 157 references indexed in Scilit:
- Deep Learning‐Driven Exploration of Pyrroloquinoline Quinone Neuroprotective Activity in Alzheimer's DiseaseAdvanced Science, 2024
- Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine LearningMovement Disorders, 2022
- Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models2020
- Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosisAnnals of Clinical and Translational Neurology, 2020
- From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacologyMedicinal Research Reviews, 2020
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018JAMA, 2020
- Comprehensive Exploration of Target‐specific Ligands Using a Graph Convolution Neural NetworkMolecular Informatics, 2019
- Identification of drug–target interactions via fuzzy bipartite local modelNeural Computing and Applications, 2019
- Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screeningMedicinal Chemistry Research, 2017
- Molecular Similarity Concepts for Informatics Applications2016